Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01374360 · ClinicalTrials.gov registry record

Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry

A clinical trial, sponsored by Alexion Pharmaceuticals.

Completed
Registry status
6,061
Enrollment target

NCT01374360 is a clinical trial that has completed, run by Alexion Pharmaceuticals. The registered enrollment target is 6,061 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01374360 has completed, sponsored by Alexion Pharmaceuticals.

COMPLETED
Registry status
6,061 participants
Enrollment target

Study Summary

This study is a collection of data to evaluate safety and characterize progression of Paroxysmal Nocturnal Hemoglobinuria (PNH).

Trial Details

FieldValue
Enrollment Target 6,061 participants
Start Date 2004-10-29
Est. Completion 2025-04-14

Sponsor

Alexion Pharmaceuticals

162 total trials

What the Registry Record Tells You About NCT01374360

The ClinicalTrials.gov registry entry for NCT01374360 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6,061 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alexion Pharmaceuticals, which has 162 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01374360 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01374360 about?

NCT01374360 is a clinical study titled "Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry". This study is a collection of data to evaluate safety and characterize progression of Paroxysmal Nocturnal Hemoglobinuria (PNH).

What is the current status of trial NCT01374360?

This trial is currently completed. The enrollment target is 6,061 participants. The study started on 2004-10-29. Estimated completion is 2025-04-14.

Who is sponsoring clinical trial NCT01374360?

This trial is sponsored by Alexion Pharmaceuticals, which has 162 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.